AMCP We're the people who help patients get the medications they need at a cost they can afford. Join Us Close

February 2020 Legislative-Regulatory Briefing

AMCP Develops 2020 Policy and Advocacy Focus Areas; CMS Issues CY 2021 Advanced Notice for MA Capitation Rates and Part C and Part D Payment Policies – Part II; CMS Issues CY 2021 and 2022 Medicare Advantage and Part D Proposed Rule; CMS Releases New Guidance on Medicaid Waiver Flexibility


AMCP Policy and Advocacy Focus Areas for 2020

This AMCP webinar will be occurring on March 11, 2020 that will discuss AMCP’s Policy and Advocacy Focus Areas for 2020.


AMCP Satellite Symposium

Satellite Symposium occurring at AMCP2020

The Clinical and Economic Value of Continuous Glucose Monitoring ...

Sponsored webinar that discussed advances in continuous glucose monitoring (CGM) technology.


February 2020 AMCP News & Views

February 2020 News & Views. Read articles on AMCP 2020, Susan Cantrell's perspectives, AMCP Partnership Forum proceedings


Realizing the Promise of Pharmacy Benefit Biosimilars in the U.S....

This sponsored webinar will be occurring on March 26, 2020 that will discuss the clinical and policy issues surrounding the future success of biosimilars in the pharmacy benefit.

Understanding Insomnia: A Chronic Sleep-Wake Disorder with Signif...

Sponsored webinar that provides an overview of insomnia disorder and the current challenges in adequately treating patients.


Embracing Format v4.1 for Early, Effective Exchange of Informatio...

AMCP webinar that gave a perspective and guidance on the early, effective exchange of information relative to the recent release of AMCP Format v4.1.


Duchenne Muscular Dystrophy (DMD): Clinical Perspectives on the L...

This CE webinar will be occurring on March 24, 2020 that is sponsored, developed and presented by PRIME.

January 2020 Legislative-Regulatory Briefing

AMCP Submits Comments to HHS OIG on Proposed Revisions to AKS Safe Harbors; AMCP to Comment on White House Proposal to Allow Drug Importation; FDA Issues Draft Guidance on Interchangeable Insulin; AMCP Invited to Participate in Pharmaceutical Quality Workshop